Dr. Avindra Nath - June 27, 2022 - "Neurological complications of SARS-CoV-2"

Avi Nath

Dr. Avindra Nath
Chief, Section of Infections of the Nervous System at the National Institute of Neurological Disorders and Stroke


Dr. Avindra Nath is a physician–scientist who specializes in neuro-immunology and neurovirology. His research is focused on the clinical manifestations, pathophysiology and treatment of emerging neurological infections with a focus on HIV infection. In recent years, he has studied the neurological complications of endogenous retroviruses, Ebola, Zika virus and SARS-CoV-2 and conducts research on patients with undiagnosed neuroinflammatory disorders. He has served on advisory committees to the NIH, CDC, FDA and WHO. The International Society of NeuroVirology gave him the Pioneer in NeuroVirology Award for his contributions to HIV neuropathogenesis and elected him as the President of the Society. He received the Wybran award from the Society of Neuroimmune Pharmacology for contributions to Neurovirology. He also received the NIH Director’s award for his work on SARS-CoV-2 and the HHS Secretary’s award for his work on Ebola infection. Dr. Nath is the Clinical Director of the National Institute of Neurological Disorders and Stroke (NINDS) at NIH, where he is also Chief of the Section of Infections of the Nervous System, Director of the Translational Center for Neurological Sciences. Dr. Nath received his medical degree from Christian Medical College in Ludhiana, India, and completed a residency in neurology from the University of Texas Health Science Center in Houston, followed by a fellowship in multiple sclerosis and neurovirology at the same institution. He then completed a fellowship in neuro-AIDS at NINDS. Having held faculty positions at the University of Manitoba and the University of Kentucky, he joined Johns Hopkins University in 2002 as Professor of Neurology and Director of the Division of Neuroimmunology and Neurological Infections. He joined NIH in 2011.